Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Neurocrit Care. 2020 Feb;32(1):238–251. doi: 10.1007/s12028-018-0650-5

Table 4.

Cohorts in which blood flow was examined after SAH

Species SAH method Time after SAH Measurement technique Regions examined Lowest perfusion (% of control) Worsening over time Refs.

Mouse PCI 2 days LSF, MRI MCA territory (LSF); forebrain, midbrain, hindbrain (MRI) 77% in MCA territory 46% in forebrain [43]
Mouse EVP 1–3 days OCT Cerebral cortex 83% on day 3 in MCA territory Yes [14]
Rat CMI 3–5 days PW-MRI ? 56% on day 5 No [16]
Rat CMI 3 min–5 days H2 clearance Parietal, occipital, cerebellar cortex 60% on day 0 globally No [53]
Rat CMI 3 h–14 days 14C autoradiography Whole brain, frontal and parieto-occipital cortex, diencephalon, brainstem, cerebellum No hypoperfusiona No [52]
Rat PCI 1 h–4 days 14C autoradiography Cerebral cortex 40% on day 2 Yes [15]
Rat PCI 3 days 14C autoradiography Cerebral cortex 50% [69]
Rat EVP 1 h–9 days MRI Single slice 0.5 cm anterior to bregma 88% on day 2 ipsilateral to EVPa No [22]
Rabbit CMI 6 days H2 clearance Cerebral cortex (bilateral frontal and parietal) 130%a [87]
Dog CMI 1–8 days Microspheres Cerebral cortex, cerebellum, pons, medulla 75% on day 8 in pons and medullaa Yes [13]
Dog CMI 7 days H2 clearance Cerebral (occipital) cortex 57% [108]
Dog CMI 5 days Microspheres Cerebral cortex, cerebellum, brain stem No hypoperfusiona [109]
Dog CMI 8 days Microspheres Cerebral cortex, cerebellum, brain stem No hypoperfusiona [109]
Primate PVC 7 days H2 clearance Cerebral cortex 44% in frontal lobeb [134]
Primate PVC 7 days 133Xe clearance Cerebral cortex 88% in right hemisphereb [128]
Primate PVC 7–14 days 133Xe clearance Cerebral cortex No hypoperfusionb No [127]
Primate PCI 0–21 days 133Xe clearance Cerebral cortex No hypoperfusionb No [144]
Primate PCI 7 days 133Xe clearance Cerebral cortex No hypoperfusionb [143]

Cohorts are sorted by species followed by SAH method. Region with lowest perfusion is also indicated when specified in the report

a

No statistical difference compared with sham

b

No comparison with sham

CMI cisterna magna blood injection ×1–3, EVP endovascular perforation of internal carotid artery terminus, LSF laser speckle flowmetry, MRI magnetic resonance imaging, OCT optical coherence tomography-based microangiography, PCI prechiasmatic blood injection, PVC perivascular clot placement, PW-MRI perfusion weighted magnetic resonance imaging using masseter muscle to calculate relative regional CBF and CBV, SAH subarachnoid hemorrhage, ? not specified, 133Xe intraarterial 133Xenon clearance